Duke CTSA

杜克大学CTSA

• 批准号: 10406180
• 负责人: JENNIFER S LI
• 金额: $ 978.16万
• 依托单位: DUKE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2018
• 资助国家: 美国
• 起止时间: 2018-05-02 至 2024-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10406180
• 关键词: Achievement; Address; Arts; Businesses; Clinical; Clinical Sciences; Clinical and Translational Science Awards; Collaborations; Communities; Data Science; Discipline of Nursing; Diverse Workforce; Engineering; Ensure; Entrepreneurship; Faculty; Fostering; Funding; Future; Goals; Health; Health Benefit; Health Sciences; Healthcare Systems; Industry; Infrastructure; Institutes; Institution; Methods; Mission; Multi-Institutional Clinical Trial; National Center for Advancing Translational Sciences; Outcome Measure; Patients; Phase; Play; Policy Maker; Population; Process; Public Health; Regulatory Affairs; Research; Research Personnel; Resources; Role; Science; Scientist; Services; Team Process; Training; Translational Research; Translations; Trust; United States; United States National Institutes of Health; Universities; Work; experience; health care delivery; improved; informatics tool; innovation; medical schools; population health; programs; skills

The mission of the Duke Clinical and Translational Science Institute is to catalyze the translation of scientific discoveries into population health benefits through collaborative research. With previous Clinical and Translational Science Award (CTSA) funding, we have successfully developed infrastructure and provided resources to support investigators across the clinical and translational scientific and workforce spectrums. Our achievements have facilitated high-impact discoveries, increased research efficiency, and nurtured a more capable and diverse workforce. We have also ignited a new era of collaborative science at Duke. Several new transdisciplinary programs have been launched, connecting trainees and faculty from our Schools of Medicine, Nursing, Engineering, Business, and Arts and Sciences to enhance translation. In the next phase, Duke proposes to capitalize on new opportunities with three broad initiatives. First, we will optimize clinical and translational science national networks’ methods and processes. Building on Duke’s leading experience coordinating multi-center clinical trials including its national Duke-Vanderbilt NCATS Trial Innovation Center, we will develop methods to optimize ‘local hub,’ ‘hub-to-network’ and ‘network-to-network’ processes for the NCATS Trial Innovation Network. We will also help investigators leverage a number of additional NIH network resources and provide methods to disseminate best practices throughout the CTSA network. Second, we will deepen, nurture, and extend stakeholder collaborations. We will strengthen existing partnerships and foster new ones with stakeholders at both the institutional and investigator levels. Partnerships and programs will expand the breadth and transparency of CTSI activities. We will also support investigators’ greater engagement with a broad range of patients, community groups, clinicians, health care systems, industry, venture capitalists, payers, policy makers, and others. Third, we will catalyze further science integration at Duke. An invigorated professional workforce will facilitate major transdisciplinary science initiatives. A new University-wide coordination infrastructure will further amplify collaboration and bridge science siloes. We will also support teams by improving their skills in team science, studying team processes, and by promoting the recognition of team contributions at our institution. Collectively, these activities will amplify the innovation and impact of our research nationally, regionally, and locally. We will measure outcomes that reflect improvement in the translation of discoveries, use of national best practices, institutional and investigator teamwork, research transparency, and community trust. We will share all best practices with the CTSA network. We believe our achievements will meaningfully enhance the impact of clinical and translational science on health across the United States.

杜克临床和转化科学研究所的任务是催化科学的翻译 通过合作研究发现人口健康受益。与以前的临床和 转化科学奖（CTSA）资金，我们已经成功开发了基础设施并提供了 支持临床和翻译科学和劳动力谱系的研究人员的资源。我们的 成就已经制定了高影响力的发现，提高了研究效率，并提高了更多的护理 有能力且潜水员的劳动力。我们还点燃了杜克大学合作科学的新时代。几个新 已经启动了跨学科计划 护理，工程，商业以及艺术和科学，以增强翻译。在下一个阶段，杜克 通过三个广泛的举措来利用新机会的建议。首先，我们将优化临床和 转化科学国家网络的方法和过程。建立在杜克的领先经验的基础上 协调多中心临床试验，包括其国家杜克 - 范德比尔特NCATS试用创新中心 我们将开发用于优化“本地枢纽”，“枢纽到网络”和“网络网络网络”过程的方法 NCATS试用创新网络。我们还将帮助调查人员利用许多其他NIH网络 资源并提供在整个CTSA网络中传播最佳实践的方法。第二，我们会的 加深，护士并扩展利益相关者的合作。我们将加强现有合作伙伴关系并寄养 在机构和研究人员层面上都有利益相关者的新成员。伙伴关系和计划将 扩大CTSI活动的广度和透明度。我们还将支持调查人员的更大 与广泛的患者，社区团体，临床医生，卫生保健系统，行业互动， 风险资本家，付款人，政策制定者等。第三，我们将催化进一步的科学整合 公爵。充满活力的专业劳动力将支持主要的跨学科科学计划。一个新 全大学协调基础设施将进一步扩大合作和桥梁科学孤岛。我们将 还通过提高团队科学技能，学习团队流程以及促进团队的技能来支持团队 认可我们机构的团队贡献。总的来说，这些活动将扩大创新和 我们在全国，地区和本地研究的影响。我们将衡量反映改进的结果 在发现发现，使用国家最佳实践，机构和调查员团队合作中 研究透明度和社区信任。我们将与CTSA网络共享所有最佳实践。我们 相信我们的成就将有意义地增强临床和转化科学对健康的影响 整个美国。